257 related articles for article (PubMed ID: 26558747)
1. Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.
Becker MO; Riemekasten G
Expert Rev Clin Immunol; 2016; 12(2):115-35. PubMed ID: 26558747
[TBL] [Abstract][Full Text] [Related]
2. An update on biomarker discovery and use in systemic sclerosis.
Matsushita T; Takehara K
Expert Rev Mol Diagn; 2017 Sep; 17(9):823-833. PubMed ID: 28730919
[TBL] [Abstract][Full Text] [Related]
3. A role for lysophosphatidic acid and sphingosine 1-phosphate in the pathogenesis of systemic sclerosis.
Pattanaik D; Postlethwaite AE
Discov Med; 2010 Aug; 10(51):161-7. PubMed ID: 20807477
[TBL] [Abstract][Full Text] [Related]
4. Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis.
Chora I; Guiducci S; Manetti M; Romano E; Mazzotta C; Bellando-Randone S; Ibba-Manneschi L; Matucci-Cerinic M; Soares R
Autoimmun Rev; 2015 Apr; 14(4):314-22. PubMed ID: 25485941
[TBL] [Abstract][Full Text] [Related]
5. Systemic sclerosis: a prototypic multisystem fibrotic disorder.
Varga J; Abraham D
J Clin Invest; 2007 Mar; 117(3):557-67. PubMed ID: 17332883
[TBL] [Abstract][Full Text] [Related]
6. Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment.
Affandi AJ; Radstake TR; Marut W
Semin Immunopathol; 2015 Sep; 37(5):475-87. PubMed ID: 26168983
[TBL] [Abstract][Full Text] [Related]
7. Vasculopathy in scleroderma.
Asano Y; Sato S
Semin Immunopathol; 2015 Sep; 37(5):489-500. PubMed ID: 26152638
[TBL] [Abstract][Full Text] [Related]
8. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
Hanitsch LG; Burmester GR; Witt C; Hunzelmann N; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Müller-Ladner U; Schulze-Lohoff E; Becker M; Sunderkoetter C; ; Riemekasten G
Rheumatology (Oxford); 2009 Jan; 48(1):70-3. PubMed ID: 19056798
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panels.
Smeets RL; Kersten BE; Joosten I; Kaffa C; Alkema W; Koenen HJPM; Vonk MC
Autoimmun Rev; 2020 May; 19(5):102515. PubMed ID: 32173517
[TBL] [Abstract][Full Text] [Related]
10. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
[TBL] [Abstract][Full Text] [Related]
11. The pathogenesis of systemic sclerosis.
Katsumoto TR; Whitfield ML; Connolly MK
Annu Rev Pathol; 2011; 6():509-37. PubMed ID: 21090968
[TBL] [Abstract][Full Text] [Related]
12. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis.
Wohlfahrt T; Usherenko S; Englbrecht M; Dees C; Weber S; Beyer C; Gelse K; Distler O; Schett G; Distler JH; Ramming A
Ann Rheum Dis; 2016 Mar; 75(3):623-6. PubMed ID: 26338035
[TBL] [Abstract][Full Text] [Related]
13. Systemic sclerosis sine scleroderma.
Kucharz EJ; Kopeć-Mędrek M
Adv Clin Exp Med; 2017 Aug; 26(5):875-880. PubMed ID: 29068586
[TBL] [Abstract][Full Text] [Related]
14. Systemic sclerosis: Is the epithelium a missing piece of the pathogenic puzzle?
Asano Y; Takahashi T; Saigusa R
J Dermatol Sci; 2019 May; 94(2):259-265. PubMed ID: 31079997
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
16. Macro- and microvascular disease in systemic sclerosis.
Kavian N; Batteux F
Vascul Pharmacol; 2015 Aug; 71():16-23. PubMed ID: 26044180
[TBL] [Abstract][Full Text] [Related]
17. Systemic sclerosis (scleroderma).
Roufosse FE; de Bellefon LM
Acta Clin Belg; 2007; 62(5):323-9. PubMed ID: 18229466
[TBL] [Abstract][Full Text] [Related]
18. Autoimmunity and vascular involvement in systemic sclerosis (SSc).
Kahaleh MB; LeRoy EC
Autoimmunity; 1999; 31(3):195-214. PubMed ID: 10739336
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and serological diversity in systemic sclerosis].
Wielosz E; Majdan M
Wiad Lek; 2018; 71(1 pt 1):78-83. PubMed ID: 29558356
[TBL] [Abstract][Full Text] [Related]
20. Immunogenetics of systemic sclerosis: Defining heritability, functional variants and shared-autoimmunity pathways.
Bossini-Castillo L; López-Isac E; Martín J
J Autoimmun; 2015 Nov; 64():53-65. PubMed ID: 26212856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
